novartis pharma
Trade trend analysis
Mon
|
Year
Number of Transactions Quantity Weight
Number of Transactions Quantity Weight
The above chart presents the market trend analysis for novartis pharma from 2025 to 2026. By examining various dimensions such as transaction quantity, transaction weight, average price, and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability. As of 2026, the company has completed 115 transactions, with a transaction quantity of 75931.11 and a transaction weight of 10.84.
- Year Transactions Quantity Weight
- 2025 560 634598.62 154.5
- 2026 115 75931.11 10.84
Bill of lading data
< 1/15 >- Trade date 2026/03/26 B/L No. cec2026kl510078
- Suppliers novartis ecuador s.a. Buyers novartis pharma
- POLs quito PODs amsterdam-amsterdam-schiphol airport
- Supply area Ecuador Purchas area Switzerland
- Weight 10.84kg Amount 165857.02
- Hs code 3002159000 Product tags injection syringe,buffer solution,concentrated solution
- Product description SIMULECT LYVI 20MG GLW (X) R234 Expand
- Trade date 2026/02/28 B/L No. 3642856
- Suppliers j b chemicals pharmaceuticals ltd. Buyers novartis pharma
- POLs jawaharlal nehru (nhava sheva) PODs rotterdam
- Supply area India Purchas area Switzerland
- Weight —— Amount 12580825.4
- Hs code 29224990 Product tags diclofenac sodium ep
- Product description DICLOFENAC SODIUM EP Expand
- Trade date 2026/02/28 B/L No. 2623521
- Suppliers jubilant biosys ltd. Buyers novartis pharma
- POLs delhi PODs zurich
- Supply area India Purchas area Switzerland
- Weight —— Amount 902
- Hs code 29339990 Product tags aromatic compound,hetero,cycle
- Product description SUBSTITUTED HETEROCYCLE AROMATIC COMPOUNDS Expand
- Trade date 2026/02/27 B/L No. 2856454
- Suppliers intonation research laboratories pvt ltd. Buyers novartis pharma
- POLs hyderabad PODs basel
- Supply area India Purchas area Switzerland
- Weight —— Amount 245019.4
- Hs code 29339990 Product tags azaindole,riva
- Product description TGT A O 2025 0656 01 5 AZAINDOLE DERIVATIVE Expand
- Trade date 2026/02/27 B/L No. 8315131
- Suppliers intonation research laboratories pvt ltd. Buyers novartis pharma
- POLs hyderabad PODs basel
- Supply area India Purchas area Switzerland
- Weight —— Amount 257270.35
- Hs code 29339990 Product tags azaindole,riva
- Product description TGT B O 2025 0656 01 6 AZAINDOLE DERIVATIVE Expand
- Trade date 2026/02/27 B/L No. 2487364
- Suppliers novartis healthcare pvt ltd. Buyers novartis pharma
- POLs hyderabad PODs basel
- Supply area India Purchas area Switzerland
- Weight —— Amount 12436.2
- Hs code 30049099 Product tags h pur,sear,r pharm,sachet
- Product description KLU156 100 120 MG FOR PHARMACEUTICAL RESEARCH PURPOSE 24 SACHETS Expand
- Trade date 2026/02/27 B/L No. 5821773
- Suppliers novartis healthcare pvt ltd. Buyers novartis pharma
- POLs hyderabad PODs basel
- Supply area India Purchas area Switzerland
- Weight —— Amount 12436.2
- Hs code 30049099 Product tags h pur,sear,r pharm,sachet
- Product description KLU156 400 480 MG FOR PHARMACEUTICAL RESEARCH PURPOSE 24 SACHETS Expand
- Trade date 2026/02/26 B/L No. 3463273
- Suppliers aragen life sciences pvt ltd. Buyers novartis pharma
- POLs hyderabad PODs zurich
- Supply area India Purchas area Switzerland
- Weight —— Amount 39840097.37
- Hs code 29332990 Product tags mat,piperidin,l car,fluoro,benzyl,sulfonyl,cyclopropyl
- Product description BENZYL 3R 4R 1 CYCLOPROPYLSULFONYL 3 FLUOROPIPERIDIN 4 YL CARBAMATE Expand
- Trade date 2026/02/25 B/L No. 7085165
- Suppliers novartis healthcare pvt ltd. Buyers novartis pharma
- POLs hyderabad PODs zurich
- Supply area India Purchas area Switzerland
- Weight —— Amount 202950
- Hs code 30049099 Product tags ting,500 t,hg
- Product description IWY357 HGC 150 MG QTY 500 TABLETS SAMPLES FOR TESTING PURPOSE ONLY Expand
- Trade date 2026/02/25 B/L No. 7834213
- Suppliers novartis healthcare pvt ltd. Buyers novartis pharma
- POLs hyderabad PODs zurich
- Supply area India Purchas area Switzerland
- Weight —— Amount 129543.76
- Hs code 30049099 Product tags ting,hg,tablets sample
- Product description IWY357 HGC 150MG QTY 250 TABLETS SAMPLES FOR TESTING PURPOSE ONLY Expand
- Trade date 2026/02/25 B/L No. 7220762
- Suppliers novartis healthcare pvt ltd. Buyers novartis pharma
- POLs hyderabad PODs zurich
- Supply area India Purchas area Switzerland
- Weight —— Amount 155452.49
- Hs code 30049099 Product tags ting,hg,tablets sample
- Product description IWY357 HGC 50 MG QTY 300 TABLETS SAMPLES FOR TESTING PURPOSE ONLY Expand
- Trade date 2026/02/25 B/L No. 1866050
- Suppliers novartis healthcare pvt ltd. Buyers novartis pharma
- POLs hyderabad PODs zurich
- Supply area India Purchas area Switzerland
- Weight —— Amount 93271.5
- Hs code 30049099 Product tags ting,fct,tablets sample
- Product description LOU064 FCT 100 MG QTY 180 TABLETS SAMPLES FOR TESTING PURPOSE ONLY Expand
- Trade date 2026/02/25 B/L No. 4426212
- Suppliers novartis healthcare pvt ltd. Buyers novartis pharma
- POLs hyderabad PODs zurich
- Supply area India Purchas area Switzerland
- Weight —— Amount 202950
- Hs code 30049099 Product tags ting,500 t,hg
- Product description IWY357 HGC 50 MG QTY 500 TABLETS SAMPLES FOR TESTING PURPOSE ONLY Expand
- Trade date 2026/02/24 B/L No. 1611637
- Suppliers novartis healthcare pvt ltd. Buyers novartis pharma
- POLs hyderabad PODs zurich
- Supply area India Purchas area Switzerland
- Weight —— Amount 155452.5
- Hs code 30049099 Product tags ting,fct,tablets sample
- Product description BAF312 FCT0 1 MG QTY 300 TABLETS SAMPLE FOR TESTING PURPOSE ONLY Expand
- Trade date 2026/02/21 B/L No. 3252183
- Suppliers novartis healthcare pvt ltd. Buyers novartis pharma
- POLs hyderabad PODs basel
- Supply area India Purchas area Switzerland
- Weight —— Amount 15402.46
- Hs code 29335990 Product tags vial,sear,ev,h pur,r pharm
- Product description IEV407 NXA NET QTY 4 VIAL X 0 5 G EACH FOR PHARMACEUTICAL RESEARCH PURPOSE Expand
Partners
Total 159- Rank Company Transactions Per Detail
- 1 novartis sağlik gidave tarim ürünl.san.ve tic.a.ş. turkeybuyer,they trade on 2023-06-27 9966 55.19% >
- 2 novartis healthcare pvt ltd. indiabuyer,they trade on 2026-02-27 1866 10.33% >
- 3 aurigene discovery technologies ltd. indiasupplier,they trade on 2020-08-24 1446 8.01% >
- 4 aragen life sciences pvt ltd. indiasupplier,they trade on 2026-02-26 845 4.68% >
- 5 usv ltd. indiasupplier,they trade on 2026-01-23 399 2.21% > +View All
Products
Total 484- Products Transactions Per Detail
-
tablet
617 46.43% > -
fct
419 31.53% > -
galvus
248 18.66% > -
sear
221 16.63% > -
h pur
201 15.12% >
+View All
Hscode rank
Total 391- HSCode Name Transactions Per Detail
- HS 300490000000 526 39.58% >
- HS 30049099 253 19.04% >
- HS 29335990 128 9.63% >
- HS 29332990 47 3.54% >
- HS 29252990 44 3.31% > +View All
Trading Area
Total 22- Area Transactions Per Detail
- turkey 9967 55.19% >
- india 6152 34.06% >
- other 95 0.53% >
- ukraine 64 0.35% >
- indonesia 16 0.09% > +View All
Port statistics
Total 49- Port Name Transactions Per Detail
- zurich 1674 9.27% >
- basle 1226 6.79% >
- basel 1021 5.65% >
- rotterdam 478 2.65% >
- mulhouse basel 216 1.2% > +View All
novartis pharma is International Buyer&Supplier,
and primarily engages in the import and export business of products such as tablet，fct，galvus.
According to the 52wmb.com global trade database, as of 2026-03-26, the company has completed 25540 international trades,
with its main trading regions covering turkey，india,other etc.
The core products include HS300490000000，HS30049099，HS29335990 etc,
often transported via zurich，port basle, port basel etc,
and its main trading partners are novartis sağlik gidave tarim ürünl.san.ve tic.a.ş.，novartis healthcare pvt ltd.，aurigene discovery technologies ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on novartis pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.
Reference contact info
Email Hunting Tool